clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Study Identifies Key Factors for Long-Term Weight Loss with GLP-1 Medications
Coronavirus
AI Effectively Allocates Resources in Pandemic
News & Features
New Therapy Shows Promise in Targeting Tau Tangles in Alzheimer’s Disease
News & Features
AFib Three Times More Common than Thought
News & Features
Better Heart Health Early on May Offset Risk of Pregnancy-Related Hypertension
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Guardant Health Files for IPO, Seeking to Raise $100M
Health care economics
Molecular Dx
Guardant Health Files for IPO, Seeking to Raise $100M
Inside Precision Medicine Staff Writer
-
September 6, 2018
0
Molecular Dx
Metabolon Raises $7.3M in Equity Financing
Inside Precision Medicine Staff Writer
-
August 30, 2018
0
Molecular Dx
Biocept to Study Clinical Utility, Cost Effectiveness of Assays in NSCLC Patients
Inside Precision Medicine Staff Writer
-
August 6, 2018
0
News & Features
Consortium Seeks Regulatory Qualification of Biomarkers for Knee OA
Inside Precision Medicine Staff Writer
-
August 2, 2018
0
News & Features
Five Products Poised to Make an Impact
Chris Anderson
-
August 2, 2018
0
Molecular Dx
Doudna and Partners’ CRISPR-Based Biomarker Detection Startup Wins $23M Series A Financing
Inside Precision Medicine Staff Writer
-
August 1, 2018
0
Molecular Dx
Go Ask ALICE: Igenomix Launches MDx for Chronic Endometritis
Inside Precision Medicine Staff Writer
-
July 30, 2018
0
Informatics
AI-Based Rare Disease Drug Repurposer Healx Raises $10M Series A Financing
Inside Precision Medicine Staff Writer
-
July 30, 2018
0
Informatics
Agendia Eyes Commercial Expansion, Collaborations with $35M Financing
Inside Precision Medicine Staff Writer
-
July 26, 2018
0
News & Features
Craig Venter’s Laptop Use at Center of HLI’s Lawsuit of Venter Institute
Inside Precision Medicine Staff Writer
-
July 23, 2018
0
1
...
19
20
21
...
27
Page 20 of 27
Related Content
Five Features Underlie Immunotherapy Response
Cancer Trials Exclude Individuals of African and Middle Eastern Ancestry Due to Duffy Blood Group
Leapfrog Bio Screens Clinical Stage Drugs to Jump into Cancer Markets
Lateral Flow Test Troubleshooting Deconstructed
Inside Precision Medicine
![The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a project designed to seek regulatory qualification of new biomarkers that predict the change in joint damage over time from osteoarthritis (OA) in the knee. [Source: American Academy of Orthopaedic Surgeons]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1817.jpeg "Consortium Seeks Regulatory Qualification of Biomarkers for Knee OA")
